Testing effectiveness (Phase 2)Study completedNCT02272855
What this trial is testing
Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Who this might be right for
Malignant Melanoma
Takara Bio Inc. 46